Skip to main content
SpringerLink
Log in

Screening for gastric cancer

  • Chapter
Advances in Cancer Screening

Part of the book series: Cancer Treatment and Research ((CTAR,volume 86))

Abstract

The decline of the incidence of stomach cancer in western countries is a well-known phenomenon [1]. Nevertheless, in 1985, it was still the second most common cancer in the world, and the most common cancer in developing countries [2]. Symptoms are rather non-specific, so most cases are diagnosed when the tumor has already invaded the muscular layer. The prognosis is then very poor: five-year relative survival was 18% for all incident cases in the U.S.A. around 1987 [3], and it was 19% in Europe around 1984 [4]. In contrast, survival is extremely good for early cancers: in the Japanese series, the five-year relative survival is 98% [5], and in the U.S.A. it is 70% [6].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Howson CP, Hiyama T, Wynder EL. 1986. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 8:1–27.

    PubMed  CAS  Google Scholar 

  2. Parkin DM, Pisani P, Ferlay J. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606.

    Article  PubMed  CAS  Google Scholar 

  3. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK (eds.). 1994. SEER Cancer Statistics Review, 1973–1991: Tables and Graphs (NIH Pub. No. 94-2789). Bethesda, MD: National Cancer Institute.

    Google Scholar 

  4. Berrino F, Sant M, Verdecchia R, Capocaccia T, Hakulinen T, Esteve J. 1995. Survival of Cancer Patients in Europe: The EUROCARE Study (IARC Sci. Publ. No. 132). Lyon: International Agency for Research on Cancer.

    Google Scholar 

  5. Japanese Research Society for Gastric Cancer. 1985. The General Rules for the Gastric Cancer Study, 11th edition. Tokyo: Kanehara Shuppan (in Japanese).

    Google Scholar 

  6. Bringaze WL, Chappuis CW, Cohn I, Correa P. 1986. Early gastric cancer: 21-year experience. Ann Surg 204:103–107.

    Article  PubMed  Google Scholar 

  7. Kurihara M, Aoki K, Hisamichi S. 1989. Cancer Mortality Statistics in the World 1950–1985. Nagoya: University of Nagoya Press.

    Google Scholar 

  8. Oshirna A. 1988. Screening for stomach cancer: the Japanese program. In Chamberlain J, Miller AB (eds.), Screening for Gastrointestinal Cancer. Toronto: Hans Huber Publishers (for UICC), pp. 65–70.

    Google Scholar 

  9. Hisamichi S, Fukao A, Sugawara N, Nishikouri M, Komatsu S, Tsuji I, Tsubono Y, Takano A. 1991. Evaluation of mass screening programme for stomach cancer in Japan. In Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds.), Cancer Screening. Cambridge, U.K.: Cambridge University Press (for UICC), pp. 357–370.

    Google Scholar 

  10. Fujita S, Hattori T. 1977. Cell proliferation, differentiation, and migration in the gastric mucosa: a study on the background of carcinogenesis. In Farger E (ed.), Pathophysiology of Carcinogenesis in Digestive Disease Organs. Tokyo: University of Tokyo Press, pp. 21–36.

    Google Scholar 

  11. Correa P. 1992. Human gastric carcinogenesis: a multistep and multifactorial process — First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res 52:6735–6740.

    PubMed  CAS  Google Scholar 

  12. Morrison AS (ed.). 1985. Screening in Chronic Disease. Oxford: Oxford University Press.

    Google Scholar 

  13. Kuroishi T, Hirose K, Tajima K, Tominaga S. 1994. Cancer Mortality in Japan (1950–1990). GANN Monogr Cancer Res 41:1–105.

    Google Scholar 

  14. Kuroishi T, Hirose K, Nakagawa N, Tominaga S. 1983. Comparison of time trends of stomach cancer death rates between the model area of the screening program and the control area. J Gastroenterol Mass Survey 58:45–52 (in Japanese).

    Google Scholar 

  15. Oshima A, Hanai A, Fujimoto I. 1979. Evaluation of a mass screening program for stomach cancer. NCI Monogr 53:181–186.

    Google Scholar 

  16. Fukao A, Hisamichi S, Komatsu S, Shimizu H, Satoh H, Nakatsuka H, Watanabe T, Fujisaku S, Ichinowatari Y, Kuroda S, Ida Y, Suda S, Kato K, Ikeda M. 1992. Comparison of characteristics between frequent participants and non-participants in screening program for stomach cancer. Tohoku J Exp Med 166:459–469.

    Article  PubMed  CAS  Google Scholar 

  17. Moss SM. 1991. Case-control studies of screening. Int J Epidemiol 20:1–6.

    Article  PubMed  CAS  Google Scholar 

  18. Friedman DR, Dubin N. 1991. Case-control evaluation of breast cancer screening efficacy. Am J Epidemiol 133:974–984.

    PubMed  CAS  Google Scholar 

  19. Oshima A, Hirata N, Ubukata T, Umeda K, Fujimoto I. 1986. Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 38:829–833.

    Article  PubMed  CAS  Google Scholar 

  20. Fukao A, Hisamichi S, Sugawara N. 1987. A case-control study on evaluating the effect of mass screening on decreasing advanced stomach cancer. J Gastroenterol Mass Survey 75:112–116 (in Japanese).

    Google Scholar 

  21. Fukao A, Tsubono Y, Tsuji I, Hisamichi S, Sugahara N, Takano A. 1995. The evaluation of screening for gastric cancer in Miyagi prefecture, Japan: a population-based case-control study. Int J Cancer 60:45–48.

    Article  PubMed  CAS  Google Scholar 

  22. Pisani P, Oliver WE, Parkin DM, Alvarez N, Vivas J. 1994. Case-control study of gastric cancer screening in Venezuela. Br J Cancer 69:1102–1105.

    Article  PubMed  CAS  Google Scholar 

  23. Samloff IM. 1971. Pepsinogens, pepsins and pepsin inhibitors. Gastroenterology 60:586–604.

    PubMed  CAS  Google Scholar 

  24. Samloff IM. 1982. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 82:26–33.

    PubMed  CAS  Google Scholar 

  25. Samloff IM, Secrist DM, Passaro E. 1975. A study of the relationship between serum group I pepsinogen levels and gastric acid secretion. Gastroenterology 69:1196–2000.

    PubMed  CAS  Google Scholar 

  26. Nomura AMY, Stemmermann GN, Samloff IM. 1980. Serum pepsinogen I as a predictor of stomach cancer. Ann Intern Med 93:537–540.

    PubMed  CAS  Google Scholar 

  27. Samloff IM, Varis K, Ibamaki T, Sicerala M, Rotter JI. 1982. Relationships among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology: a study in relatives of patients with pernicious anemia. Gastroenterology 83:204–209.

    PubMed  CAS  Google Scholar 

  28. Westerveld BD, Pals G, Lamers CBHW, Defize J, Pronk JC, Frants RR, Ooms ECM, Kreuning J, Kostense PJ, Eriksson AW, Meuwissen SGM. 1987. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 59:952–958.

    Article  PubMed  CAS  Google Scholar 

  29. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, Matsushima T, Takahashi K. 1987. Serm pepsinogens as a screening test of extensive chronic gastritis, Gastroenterol Jpn 22:133–141.

    PubMed  CAS  Google Scholar 

  30. Miki K, Ichinose M, Kawamura N, Matsushima M, Ahmad HB, Kimura M, Sano J, Tashiro T, Kakei N, Oka H, Furihata C, Takahashi K. 1989. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 80:111–114.

    PubMed  CAS  Google Scholar 

  31. Knight T, Wyatt J, Newell D, Hengels K, Corlett M, Wilson A, Greaves S, Webb P, Forman D, Elder JB. 1993. Use of serum pepsinogens and Helicobacter pylori serology for assessment of antral gastritis in population-based studies of gastric carcinogenesis (abstract). Br Soc Gastroenterol S5.

    Google Scholar 

  32. Stemmermann GN, Samloff IM, Normura AMY, Heilbrun LK. 1987. Serum pepsinogens I and II and stomach cancer. Clinica Chimica Acta 163:191–198.

    Article  CAS  Google Scholar 

  33. IARC. 1994. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 61. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: International Agency for Research on Cancer.

    Google Scholar 

  34. Megraud F, Brassens-Rabbe MP, Denis F, Belbouri A, Hoa DQ. 1989. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 27:1870–1873.

    PubMed  CAS  Google Scholar 

  35. The Eurogast Study Group. 1993. An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:1359–1362.

    Article  Google Scholar 

Download references

Authors
  1. Paola Pisani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Maxwell Parkin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Toronto, Canada

    Anthony B. Miller

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Kluwer Academic Publishers

About this chapter

Cite this chapter

Pisani, P., Parkin, D.M. (1996). Screening for gastric cancer. In: Miller, A.B. (eds) Advances in Cancer Screening. Cancer Treatment and Research, vol 86. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1265-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1265-9_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8539-7

  • Online ISBN: 978-1-4613-1265-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation